Low interim influenza vaccine effectiveness, Australia, 1 May to 24 September 2017

    Thumbnail
    Download
    Citations
    Scopus
    Web of Science
    Altmetric
    52
    40
    Author
    Sullivan, SG; Chilver, MB; Carville, KS; Deng, Y-M; Grant, KA; Higgins, G; Komadina, N; Leung, VKY; Minney-Smith, CA; Teng, D; ...
    Date
    2017-10-26
    Source Title
    Eurosurveillance
    Publisher
    EUR CENTRE DIS PREVENTION & CONTROL
    University of Melbourne Author/s
    Sullivan, Sheena
    Affiliation
    Doherty Institute
    Metadata
    Show full item record
    Document Type
    Journal Article
    Citations
    Sullivan, S. G., Chilver, M. B., Carville, K. S., Deng, Y. -M., Grant, K. A., Higgins, G., Komadina, N., Leung, V. K. Y., Minney-Smith, C. A., Teng, D., Tran, T., Stocks, N. & Fielding, J. E. (2017). Low interim influenza vaccine effectiveness, Australia, 1 May to 24 September 2017. EUROSURVEILLANCE, 22 (43), pp.2-8. https://doi.org/10.2807/1560-7917.ES.2017.22.43.17-00707.
    Access Status
    Open Access
    URI
    http://hdl.handle.net/11343/257449
    DOI
    10.2807/1560-7917.ES.2017.22.43.17-00707
    Abstract
    In 2017, influenza seasonal activity was high in the southern hemisphere. We present interim influenza vaccine effectiveness (VE) estimates from Australia. Adjusted VE was low overall at 33% (95% confidence interval (CI): 17 to 46), 50% (95% CI: 8 to 74) for A(H1)pdm09, 10% (95% CI: -16 to 31) for A(H3) and 57% (95% CI: 41 to 69) for influenza B. For A(H3), VE was poorer for those vaccinated in the current and prior seasons.

    Export Reference in RIS Format     

    Publisher licence
    CC BY
    Collections